The Primatene Mist inhaler is the only over-the-counter (OTC) asthma inhaler approved by the FDA for the relief of asthma symptoms including wheezing, chest tightness, and shortness of breath in ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Seven of these patients subsequently required emergency treatment. Alarmingly, over 30% of patients also used a medication other than a bronchodilator as their rescue inhaler.

metered dose inhaler; CFC-free. Flovent HFA is supplied in the following boxes of 1 as a pressurized aluminum canister fitted with a counter and supplied with a dark orange actuator with a peach ...

To find the best over-the-counter treatments for life's aches and pains, including allergy medicines, eye drops, and hemorrhoid treatments, we interview medical professionals, test top products ...

Despite treatment, the breathing problems tend to get worse over time, and patients may ... We are building upon our strong heritage in bronchodilator and inhaler development with ongoing clinical ...

Recent research reveals that anti-inflammatory inhalers not only cut the risk ... in symptom control compared to traditional bronchodilator treatments. Study: Inhaled Reliever Therapies for ...

Over-the counter eye drops can relieve eye issues like allergies, redness, watery eyes, itchiness and dryness-- including dry contact lenses. Picking the right one to use on the market can be ...

Compared with bronchodilator ... reliever over SABA alone, but the optimal asthma reliever strategy has been unclear since the FDA recently approved ICS-SABA as a reliever inhaler, according ...

It was only two years ago that hearing aids became available over the counter in the US, but the positive impact of these devices is long-standing. And they've proven themselves as great tools for ...

PMI's boss Jacek Olczak also said the company remains "committed to driving innovation in this space over the long-term", suggesting it has not moved on entirely from the inhaler sector.